CACI International delivered a clear earnings beat in its fiscal first quarter, reporting adjusted EPS of $7.66 against a $6.45 consensus and a $6.74 Earnings Whisper number. That was a 13.6% surprise and an 11.8% year-over-year gain. Revenue told a softer story. Sales of $2.475 billion rose 8.2% but missed the $2.50 billion consensus by 1.0%. Organic growth was only 2.1%. That is the central tension: profitability is outrunning the top line, and growth has cooled sharply. According to the conference-call analysis, fourth-quarter fiscal 2026 revenue grew 17.6%, including 11.6% organic. Full-year fiscal 2026 revenue rose 10.9%, with 7.2% organic. Measured against those figures, this quarter marks a real deceleration, even if it was largely telegraphed.

The margin story is strong. EBITDA climbed 22.4% to $328.8 million, and EBITDA margin expanded to 13.3% from 11.7%. Operating income rose 16.6%. Mix appears to be doing much of the work:

• Fixed-price revenue jumped 34.4% and now represents 33.2% of sales, up from 26.7%.
• Cost-plus revenue fell 5.5%.
• Technology revenue grew 11.4%, while expertise revenue grew 3.9%.

The gap between GAAP and adjusted results matters. GAAP diluted EPS rose just 3.7% to $5.84. Interest expense jumped 58.6%, and intangible amortization rose about 51%. The release does not discuss the cause, but the call materials reference ARCA-related interest costs, which points to recent acquisition financing. Cash generation also lagged. Free cash flow fell 6.6% to $133.5 million on higher working capital, and days sales outstanding rose to 59 from 56.

Investors should treat the call evidence carefully. The transcript supplied for this quarter appears to be a near-verbatim copy of the August fiscal fourth-quarter call; the operator even introduces it as the fiscal 2026 call. As a result, there is no reliable new first-quarter commentary on demand, margins, or guidance. What the prior call did establish is useful context. Management had guided first-quarter organic growth to low single digits and described fiscal 2027 as back-half weighted, with roughly a 45/55 revenue split and one-third/two-thirds free cash flow. On that basis, the 2.1% organic print looks like execution to plan rather than a surprise breakdown. The prior call also highlighted:

• the $500 million Domestic Shield counter-UAS award;
• a classified counter-space win;
• the Spectral program reaching low-rate initial production;
• deleveraging to 3.7x, with a low-3x target pulled forward to June 2027.

The forward indicators deserve scrutiny. Awards of $4.8 billion produced a 2.0x book-to-bill, with 61% new business, and the release highlights two awards of roughly $1.2 billion each from U.S. Central Command and Army Special Operations. However, awards declined 3.4% year over year. Total backlog of $34.0 billion grew just 0.3%. That extends a slowdown the call analysis traced from +6% in the third quarter to +2% in the fourth. Funded backlog still grew 14.8%, but that is well below the 29% pace cited for the fourth quarter. By customer, Department of War revenue rose 14.8%, intelligence revenue grew 2.6%, and federal civilian revenue fell 3.7%. The prior call also flagged continuing-resolution risk and procurement shifts that make award metrics less comparable.

Guidance moved up, but only modestly:

• Fiscal 2027 revenue guidance rose $50 million at each end, to $10.70-$10.90 billion.
• Adjusted EPS guidance increased $0.22 to $33.18-$34.08.
• Free cash flow guidance of at least $900 million was reaffirmed.

The EPS increase is far smaller than the quarter's $1.21 beat against consensus. That suggests management is banking only part of the outperformance, or that consensus had simply been set low for a seasonally light quarter. The raise also requires a back-half acceleration against a backlog base that is barely growing.

Investor sentiment improved from mildly negative (-0.11) to roughly neutral (+0.01). That is a meaningful shift in tone, but it does not signal enthusiasm. The stock has rallied 12.8% since opening at $552.54 after the August report. As of the report date it stood at $623.38, about 10% above its 200-day moving average of $566.33. Price trend readings are positive, while the AVWAP trend remains negative, a mixed technical backdrop. With shares already extended, the market had priced in a good deal of the margin story before the beat arrived.

The bottom line is that CACI delivered a high-quality margin quarter and a modest guidance raise, but the revenue miss, 2.1% organic growth, and essentially flat total backlog leave the fiscal 2027 story dependent on a second-half ramp that has not yet appeared in the numbers. With the call transcript apparently duplicated from August, there is no fresh management commentary to validate that ramp. That leaves investors relying on funded backlog growth and the pipeline rather than new evidence.